Brief: Egetis Announces EMA Validation For Emcitate

Egetis Therapeutics AB (publ)

27/10/2023 06:14

Oct 27 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS ANNOUNCES EMA VALIDATION OF MARKETING AUTHORISATION
APPLICATION FOR EMCITATE FOR THE TREATMENT OF MCT8 DEFICIENCY

Source text for Eikon:  ID:nMFNbMt73H 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))